These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 28659437

  • 21. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS, Kristiansen MN, Hansen HH, Veidal SS, Rigbolt KT, Gillum MP, Jelsing J, Vrang N, Feigh M.
    World J Gastroenterol; 2018 Jan 14; 24(2):179-194. PubMed ID: 29375204
    [Abstract] [Full Text] [Related]

  • 22. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G, Jackson CV, Zimmerman K, Zhang LK, Finnearty CM, Sandusky GE, Zhang G, Peterson RG, Wang YJ.
    BMC Gastroenterol; 2019 Mar 18; 19(1):41. PubMed ID: 30885145
    [Abstract] [Full Text] [Related]

  • 23. Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis.
    Kim B, Farruggia C, Ku CS, Pham TX, Yang Y, Bae M, Wegner CJ, Farrell NJ, Harness E, Park YK, Koo SI, Lee JY.
    J Nutr Biochem; 2017 May 18; 43():27-35. PubMed ID: 28193580
    [Abstract] [Full Text] [Related]

  • 24. Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non‑alcoholic fatty liver disease mouse model.
    Lu Y, Lin Y, Huang X, Wu S, Wei J, Yang C.
    Int J Mol Med; 2019 Jun 18; 43(6):2398-2408. PubMed ID: 30942432
    [Abstract] [Full Text] [Related]

  • 25. Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis.
    Dattaroy D, Pourhoseini S, Das S, Alhasson F, Seth RK, Nagarkatti M, Michelotti GA, Diehl AM, Chatterjee S.
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb 15; 308(4):G298-312. PubMed ID: 25501551
    [Abstract] [Full Text] [Related]

  • 26. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
    Larter CZ, Yeh MM, Haigh WG, Van Rooyen DM, Brooling J, Heydet D, Nolan CJ, Teoh NC, Farrell GC.
    Obesity (Silver Spring); 2013 Jun 15; 21(6):1189-99. PubMed ID: 23666886
    [Abstract] [Full Text] [Related]

  • 27. NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicity.
    Alhasson F, Dattaroy D, Das S, Chandrashekaran V, Seth RK, Schnellmann RG, Chatterjee S.
    Am J Physiol Renal Physiol; 2016 Jan 01; 310(1):F85-F101. PubMed ID: 26447219
    [Abstract] [Full Text] [Related]

  • 28. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
    Hohenester S, Christiansen S, Nagel J, Wimmer R, Artmann R, Denk G, Bischoff M, Bischoff G, Rust C.
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep 01; 315(3):G329-G338. PubMed ID: 29878845
    [Abstract] [Full Text] [Related]

  • 29. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S, Rousseau D, Bonnafous S, Lebeaupin C, Luci C, Canivet CM, Schneck AS, Bertola A, Saint-Paul MC, Iannelli A, Gugenheim J, Anty R, Tran A, Bailly-Maitre B, Gual P.
    J Hepatol; 2017 Aug 01; 67(2):328-338. PubMed ID: 28323124
    [Abstract] [Full Text] [Related]

  • 30. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH).
    Nati M, Haddad D, Birkenfeld AL, Koch CA, Chavakis T, Chatzigeorgiou A.
    Rev Endocr Metab Disord; 2016 Mar 01; 17(1):29-39. PubMed ID: 26847547
    [Abstract] [Full Text] [Related]

  • 31. Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.
    Takegoshi K, Honda M, Okada H, Takabatake R, Matsuzawa-Nagata N, Campbell JS, Nishikawa M, Shimakami T, Shirasaki T, Sakai Y, Yamashita T, Takamura T, Tanaka T, Kaneko S.
    Oncotarget; 2017 Mar 14; 8(11):18191-18205. PubMed ID: 28212548
    [Abstract] [Full Text] [Related]

  • 32. Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis.
    Jeftic I, Jovicic N, Pantic J, Arsenijevic N, Lukic ML, Pejnovic N.
    Mol Med; 2015 May 22; 21(1):453-65. PubMed ID: 26018806
    [Abstract] [Full Text] [Related]

  • 33. Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).
    Jindal A, Bruzzì S, Sutti S, Locatelli I, Bozzola C, Paternostro C, Parola M, Albano E.
    Exp Mol Pathol; 2015 Aug 22; 99(1):155-62. PubMed ID: 26112094
    [Abstract] [Full Text] [Related]

  • 34. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    Lytle KA, Wong CP, Jump DB.
    PLoS One; 2017 Aug 22; 12(4):e0173376. PubMed ID: 28422962
    [Abstract] [Full Text] [Related]

  • 35. Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH.
    Oniciu DC, Hashiguchi T, Shibazaki Y, Bisgaier CL.
    PLoS One; 2018 Aug 22; 13(5):e0194568. PubMed ID: 29847555
    [Abstract] [Full Text] [Related]

  • 36. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y, Fukusato T.
    World J Gastroenterol; 2014 Nov 14; 20(42):15539-48. PubMed ID: 25400438
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease.
    Zhang Y, Wu B, Zhang H, Ge X, Ying S, Hu M, Li W, Huang Y, Wang L, Chen C, Shan X, Liang G.
    J Cell Mol Med; 2018 Feb 14; 22(2):936-947. PubMed ID: 29077272
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of EGFR attenuates fibrosis and stellate cell activation in diet-induced model of nonalcoholic fatty liver disease.
    Liang D, Chen H, Zhao L, Zhang W, Hu J, Liu Z, Zhong P, Wang W, Wang J, Liang G.
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan 14; 1864(1):133-142. PubMed ID: 29038049
    [Abstract] [Full Text] [Related]

  • 39. [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis].
    Nakajima T, Naito H.
    Nihon Eiseigaku Zasshi; 2015 Jan 14; 70(3):197-204. PubMed ID: 26411937
    [Abstract] [Full Text] [Related]

  • 40. A gut microbial metabolite of linoleic acid ameliorates liver fibrosis by inhibiting TGF-β signaling in hepatic stellate cells.
    Kasahara N, Imi Y, Amano R, Shinohara M, Okada K, Hosokawa Y, Imamori M, Tomimoto C, Kunisawa J, Kishino S, Ogawa J, Ogawa W, Hosooka T.
    Sci Rep; 2023 Nov 03; 13(1):18983. PubMed ID: 37923895
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.